Cargando…
Efficacy and Safety of Antiintegrin Antibody for Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
We sought to evaluate the safety and efficacy of available biologics that inhibit T-cell migration by blocking α(4)β(7) integrins in inflammatory bowel diseases. The aim of this study is to evaluate whether Crohn disease (CD) patients receiving either vedolizumab or natalizumab have any different ef...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602468/ https://www.ncbi.nlm.nih.gov/pubmed/25761174 http://dx.doi.org/10.1097/MD.0000000000000556 |